Tumor Immune Infiltration and Its Association with Immune-Active Tumor Phenotypes in Muscle-Invasive Bladder Cancer: An Integrative TCGA Analysis
Onco · 08.06.2026 · 6 (2) · 27
DOI: 10.3390/onco6020027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Onco, online erschienen am 08.06.2026. Verfasst von Onyekachi Anya und 5 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Muscle-invasive bladder cancer (MIBC) is an aggressive disease with heterogeneous responses to neoadjuvant chemotherapy and emerging chemo-immunotherapy combinations. Reliable biomarkers to predict treatment responsiveness before therapy initiation are needed to guide patient selection.
Objective
The objective of this study was to identify genomic and immune-related features associated with immune-active tumor phenotypes in MIBC using The Cancer Genome Atlas bladder cancer cohort (TCGA-BLCA).
Methods
A retrospective bioinformatics analysis of TCGA-BLCA data was performed, evaluating gene expression, somatic mutations, tumor mutational burden (TMB), DNA damage response (DDR) gene status, and immune infiltration signatures. Immune enrichment metrics were derived from transcriptomic data. In the absence of direct treatment response data, a surrogate immune response classification was applied. Associations were analyzed using descriptive statistics and Firth’s penalized logistic regression.
Results
Tumors classified as immune-high phenotype group based on immune-related features exhibited significantly higher global immune infiltration, including increased ImmuneScore and enrichment of cytotoxic and innate immune cells. In multivariable analysis, ImmuneScore was the only independent predictor of inferred responsiveness (p = 0.003).
Conclusions
Global immune infiltration showed the strongest association with immune-active tumor phenotypes among the features examined in this TCGA-based analysis. These exploratory findings suggest that immune profiling may warrant further investigation as a component of tumor characterization in MIBC, pending validation in cohorts with clinical treatment and outcome data.
Zitieren
APA
Anya, O., Chikere, O., Asoluka, P., Oletu, H., Idenyi, O., & Ng, R. (2026). Tumor Immune Infiltration and Its Association with Immune-Active Tumor Phenotypes in Muscle-Invasive Bladder Cancer: An Integrative TCGA Analysis. Onco, 6(2), 27. https://doi.org/10.3390/onco6020027
Vancouver
Anya O, Chikere O, Asoluka P, Oletu H, Idenyi O, Ng R. Tumor Immune Infiltration and Its Association with Immune-Active Tumor Phenotypes in Muscle-Invasive Bladder Cancer: An Integrative TCGA Analysis. Onco. 2026;6(2):27. doi:10.3390/onco6020027
BibTeX
@article{Anya2026,
author = {Anya, Onyekachi and Chikere, Ogbonna and Asoluka, Progress and Oletu, Helen and Idenyi, Oluchi and Ng, Ronald},
title = {Tumor Immune Infiltration and Its Association with Immune-Active Tumor Phenotypes in Muscle-Invasive Bladder Cancer: An Integrative TCGA Analysis},
journal = {Onco},
year = {2026},
volume = {6},
number = {2},
pages = {27},
doi = {10.3390/onco6020027}
}
EUVIMED